BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2089292)

  • 1. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
    Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
    Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
    Sov Med; 1990; (6):26-9. PubMed ID: 2204116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic cytology and histology in the gynecologic malignant tumors].
    Sugishita T
    Gan No Rinsho; 1990 Aug; 36(10):1117-22. PubMed ID: 2214147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R
    Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of plasma ribonuclease as a marker for gynecologic tumors and breast tumors].
    Kraus H; Deinert S
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):20-2. PubMed ID: 3956957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies.
    Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P
    Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with the cancer marker CA 125 in gynecologic diseases].
    Pilgrim G; von Broen B; Johannsmeyer KD
    Z Gesamte Inn Med; 1989 Apr; 44(8):251-4. PubMed ID: 2741520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulin level in malignant gynecologic diseases and tumor patients].
    Pulay T; Keller G; Krommer K; Kovács C
    Orv Hetil; 1973 Dec; 114(52):3146-8. PubMed ID: 4766323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gynecologic malignancies].
    Kato H
    Nihon Rinsho; 1996 Jun; 54(6):1637-41. PubMed ID: 8691622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.